SCHEMBL3054702

SCHEMBL3054702

NCCCCNCCCNCCCCN

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.87
CA6 P23280 5/20 0.87
CA7 P43166 5/20 0.87
CA9 Q16790 5/20 0.87
CA14 Q9ULX7 5/20 0.87
CA5B Q9Y2D0 5/20 0.87
CA2 P00918 4/20 0.87
CA4 P22748 4/20 0.87
CA5A P35218 4/20 0.87
ALOX15 P16050 3/20 0.87
CA3 P07451 3/20 0.87
F13A1 P00488 2/20 0.87
CYP1A2 P05177 2/20 0.87
THPO P40225 2/20 0.87
CA1 P00915 2/20 0.87
CYP2C9 P11712 1/20 0.87
PKM P14618 1/20 0.87
TSHR P16473 1/20 0.87
MTOR P42345 1/20 0.87
LMNA P02545 3/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3169235 1.00 CA12 (0.87) CA12CA6CA7CA9CA14
SCHEMBL3159091 1.00 CA12 (0.87) CA12CA6CA7CA9CA14
SCHEMBL333029 0.97 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL10045118 0.97 CA12 (0.81) CA12CA6CA7CA9CA14
SCHEMBL3993770 0.97 CA12 (0.81) CA12CA6CA7CA9CA14
SCHEMBL5904795 0.97 CA12 (0.81) CA12CA6CA7CA9CA14
SCHEMBL10045116 0.97 CA12 (0.81) CA12CA6CA7CA9CA14
SCHEMBL3169101 0.97 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL3303777 0.97 CA12 (0.81) CA12CA6CA7CA9CA14
SCHEMBL3158875 0.97 CA12 (0.93) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539968-A1 TREATED MICROPOROUS MEMBRANE PPG Industries Ohio Inc. (US) 2025-04-23 EP claimed
WO-2023244892-A1 TREATED MICROPOROUS MEMBRANE PPG INDUSTRIES OHIO, INC. (US) 2023-12-21 WO claimed
EP-3541501-B1 METHODS FOR TREATING FILLED MICROPOROUS MEMBRANES PPG IND OHIO INC (US) 2023-01-04 EP claimed
CN-109952146-B Method of treating filled microporous membranes PPG工业俄亥俄公司 2022-04-01 CN claimed
US-10888824-B2 Methods for treating filled microporous membranes PPG INDUSTRIES OHIO, INC. (US) 2021-01-12 US claimed
CN-109952146-A The method for handling the microporous barrier of filling PPG工业俄亥俄公司 2019-06-28 CN claimed
US-20180133664-A1 Methods for Treating Filled Microporous Membranes PPG INDUSTRIES OHIO, INC. 2018-05-17 US claimed
US-7452845-B2 Mesoporous organic-inorganic hybrid materials for separating gases CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-11-18 US claimed
US-20060281820-A1 Lfa-1 inhibitors and use thereof SODA KUNIYASU 2006-12-14 US claimed
EP-1370563-B1 MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES CENTRE NAT RECH SCIENT (FR) 2006-09-06 EP claimed
US-20040122250-A1 Mesoporous organic-inorganic hybrid materials for separating gases CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) 2004-06-24 US claimed
US-20260125344-A1 POLYURETHANE-ACETOACETATE COMPOUNDS PPG INDUSTRIES OHIO, INC. (US) 2026-05-07 US disclosed
EP-4423059-A2 POLYURETHANE-ACETOACETATE COMPOUNDS PPG Industries Ohio, Inc. (US) 2024-09-04 EP disclosed
US-20240241079-A1 TRANSISTOR-TYPE POLYAMINE SENSOR THE UNIVERSITY OF TOKYO (JP) 2024-07-18 US disclosed
CN-118159519-A Polyurethane acetoacetate compounds PPG工业俄亥俄公司 2024-06-07 CN disclosed
US-20040122250-A1 Mesoporous organic-inorganic hybrid materials for separating gases CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) 2004-06-24 US disclosed
US-6605645-B2 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action RIKEN (JP) 2003-08-12 US disclosed
US-20020067472-A1 Linear polyamine compounds and polyamine anticancer agents IWATA MASAAKI (JP) 2002-06-06 US disclosed
US-6319956-B1 N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. RIKEN (JP) 2001-11-20 US disclosed
US-4851524-A SLUDGE DISPERSANTS EXXON RESEARCH AND ENGINEERING COMPANY (US) 1989-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122250-A1 Mesoporous organic-inorganic hybrid materials for separating gases SCO2, IPO9, IPO4 CA12 174/4885CA6 83/4885CA7 87/4885
US-20260125344-A1 POLYURETHANE-ACETOACETATE COMPOUNDS HAT1, PUF60, GAR1 CA12 801/4885CA6 810/4885CA7 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.